BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10499723)

  • 1. The prognostic significance of angiogenesis in canine mammary tumors.
    Graham JC; Myers RK
    J Vet Intern Med; 1999; 13(5):416-8. PubMed ID: 10499723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of angiogenesis in canine mammary tumors by quantitative platelet endothelial cell adhesion molecule immunohistochemistry.
    Restucci B; De Vico G; Maiolino P
    Vet Pathol; 2000 Jul; 37(4):297-301. PubMed ID: 10896390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canine mammary carcinomas: influence of histological grade, vascular invasion, proliferation, microvessel density and VEGFR2 expression on lymph node status and survival time.
    Diessler ME; Castellano MC; Portiansky EL; Burns S; Idiart JR
    Vet Comp Oncol; 2017 Jun; 15(2):450-461. PubMed ID: 26833549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cox-2 expression in canine mammary carcinomas: correlation with angiogenesis and overall survival.
    Lavalle GE; Bertagnolli AC; Tavares WL; Cassali GD
    Vet Pathol; 2009 Nov; 46(6):1275-80. PubMed ID: 19605908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral FoxP3 expression is associated with angiogenesis and prognosis in malignant canine mammary tumors.
    Carvalho MI; Pires I; Prada J; Gregório H; Lobo L; Queiroga FL
    Vet Immunol Immunopathol; 2016 Oct; 178():1-9. PubMed ID: 27496736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of the Regional Lymph Node Metastatic Burden and Prognosis in Malignant Mammary Tumors of Dogs.
    de Araújo MR; Campos LC; Ferreira E; Cassali GD
    J Vet Intern Med; 2015; 29(5):1360-7. PubMed ID: 26130166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer-assisted image analysis of intratumoral vessel density in mammary tumors from dogs.
    Griffey SM; Verstraete FJ; Kraegel SA; Lucroy MD; Madewell BR
    Am J Vet Res; 1998 Oct; 59(10):1238-42. PubMed ID: 9781454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of vascular endothelial growth factor in canine mammary tumors.
    Restucci B; Papparella S; Maiolino P; De Vico G
    Vet Pathol; 2002 Jul; 39(4):488-93. PubMed ID: 12126152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGFR and microvessel density in canine malignant mammary tumours.
    Carvalho MI; Guimarães MJ; Pires I; Prada J; Silva-Carvalho R; Lopes C; Queiroga FL
    Res Vet Sci; 2013 Dec; 95(3):1094-9. PubMed ID: 24091029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic significance of angiogenesis in canine mammary tumors.
    Rosenthal RC
    J Vet Intern Med; 2000; 14(3):248-9. PubMed ID: 10830535
    [No Abstract]   [Full Text] [Related]  

  • 11. Tryptase-positive mast cells correlate with angiogenesis in canine mammary carcinoma.
    Im KS; Kim JH; Yhee JY; Yu CH; Kim NH; Nho WG; Sur JH
    J Comp Pathol; 2011; 144(2-3):157-63. PubMed ID: 20934709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of vascular endothelial growth factor and hypoxia-inducible factor 1α in canine malignant mammary tumors.
    Moschetta MG; Maschio LB; Jardim-Perassi BV; Gelaleti GB; Lopes JR; Leonel C; Gonçalves Ndo N; Ferreira LC; Martins GR; Borin TF; Zuccari DA
    Oncol Rep; 2015 May; 33(5):2345-53. PubMed ID: 25779537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis in canine mammary tumours: a morphometric and prognostic study.
    Sleeckx N; Van Brantegem L; Van den Eynden G; Fransen E; Casteleyn C; Van Cruchten S; Veldhuis Kroeze E; Van Ginneken C
    J Comp Pathol; 2014; 150(2-3):175-83. PubMed ID: 24231306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of karyometric variables in spontaneously occurring canine mammary tumors.
    Nair BC; Kumar S; Rani S; Paliwal OP
    Anal Quant Cytol Histol; 2006 Oct; 28(5):292-6. PubMed ID: 17067011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour-associated macrophages are associated with vascular endothelial growth factor expression in canine mammary tumours.
    Raposo TP; Pires I; Carvalho MI; Prada J; Argyle DJ; Queiroga FL
    Vet Comp Oncol; 2015 Dec; 13(4):464-74. PubMed ID: 24119241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological, immunohistological, and ultrastructural description of vasculogenic mimicry in canine mammary cancer.
    Clemente M; Pérez-Alenza MD; Illera JC; Peña L
    Vet Pathol; 2010 Mar; 47(2):265-74. PubMed ID: 20106772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Occult Isolated Tumour Cells within Regional Lymph Nodes of Dogs with Malignant Mammary Tumours.
    Coleto AF; Wilson TM; Soares NP; Gundim LF; Castro IP; Guimarães EC; Bandarra MB; Medeiros-Ronchi AA
    J Comp Pathol; 2018 Jan; 158():32-38. PubMed ID: 29422313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of tissue and serum HER2 and MUC1 in canine mammary cancer.
    Campos LC; Silva JO; Santos FS; Araújo MR; Lavalle GE; Ferreira E; Cassali GD
    J Vet Diagn Invest; 2015 Jul; 27(4):531-5. PubMed ID: 26179096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High COX-2 expression is associated with increased angiogenesis, proliferation and tumoural inflammatory infiltrate in canine malignant mammary tumours: a multivariate survival study.
    Carvalho MI; Pires I; Prada J; Raposo TP; Gregório H; Lobo L; Queiroga FL
    Vet Comp Oncol; 2017 Jun; 15(2):619-631. PubMed ID: 26792550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone receptor isoform analysis by quantitative real-time polymerase chain reaction in formalin-fixed, paraffin-embedded canine mammary dysplasias and tumors.
    Guil-Luna S; Stenvang J; Brünner N; Sánchez-Céspedes R; Millán Y; Gómez-Laguna J; de las Mulas JM
    Vet Pathol; 2014 Sep; 51(5):895-902. PubMed ID: 24249219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.